Monoclonal Antibody Therapy

Monoclonal antibody therapy is a process in which monoclonal antibodies (mAb) are used to bind monospecifically to certain cells or proteins. This may then stimulate the patient's immune system to attack those cells. Alternatively, in radioimmunotherapy a radioactive dose localizes on a target cell line, delivering lethal chemical doses. More recently antibodies have been used to bind to molecules involved in T-cell regulation to remove inhibitory pathways that block T-cell responses, known as immune checkpoint therapy. It is possible to create a mAb specific to almost any extracellular/ cell surface target. Research and development is underway to create antibodies for diseases (such as rheumatoid arthritis, multiple sclerosis, Alzheimer's disease, Ebola and different types of cancers).    

The specificity of Monoclonal Antibodies allows it’s binding to cancerous cells by coupling a cytotoxic agent such as a strong radioactive which then seeks out to destroy the cancer cells while not harming the healthy ones.

  • Advantages in Monoclonal Antibody Therapy
  • Monoclonal and Polyclonal antibodies
  • Monoclonal Antibody Therapy for Cancer
  • Monoclonal Antibodies Applications
  • Hybridoma Technology and Monoclonal Antibody Preparation
  • Antibody Research in Agriculture, Aquaculture, Veterinary and Food Sciences
  • Antibody Technology in New Protein Discovery

Related Conference of Monoclonal Antibody Therapy

Monoclonal Antibody Therapy Conference Speakers